Skip to content
drillr.ai
Sign up

600211.SH

Tibet Rhodiola Pharmaceutical Holding Co.

SSE · Healthcare · Medical - Pharmaceuticals · CN

CNY 38.16
−2.13%
Ask drillr

  • Sep 6, 2026, 07:32 UTC

    Tibet Rhodiola Pharmaceutical announced a differentiated interim dividend for H1 2026, paying 1.146 yuan per share (tax included) based on 322 million total shares minus 4.0001 million shares in the buyback account, totaling 365 million yuan, representing 60% of half-year net profit attributable to shareholders.

    Source:

  • Sep 1, 2026, 09:12 UTC

    Tibet Pharmaceutical announced that as of the end of August 2026, it had repurchased 4,000,058 shares of its own stock, representing 1.24% of total shares, for a total amount of 177,595,651.46 yuan.

    Source:

  • Aug 13, 2026, 08:35 UTC

    Tibet Rhodiola Pharmaceutical proposed a cash dividend of 1.15 yuan per share (pre-tax) to all shareholders, based on total share capital excluding treasury shares.

    Source:

  • Aug 13, 2026, 08:35 UTC

    Tibet Rhodiola Pharmaceutical announced its 2026 half-year results: revenue of 1.554 billion yuan, down 5.83% year-on-year; net profit attributable to shareholders of 608 million yuan, up 7.16% year-on-year; non-recurring net profit of 440 million yuan, down 19.00% year-on-year.

    Source:

  • Jul 7, 2026, 11:52 UTC

    Zhejiang Guyuelongshan Shaoxing Wine Co., Ltd. and Tibet Nuodikang Pharmaceutical Co., Ltd. signed a strategic cooperation agreement to jointly develop a health-oriented special yellow wine.

    Source: